Coenzyme Q10 Market size to grow by USD 242.36 mn from 2021-2025|Growing disposable income to boost growth|Technavio

NEW YORK, Oct. 13, 2021 /PRNewswire/ — The coenzyme Q10 market is expected to grow by USD 242.36 million from 2021…

NEW YORK, Oct. 13, 2021 /PRNewswire/ — The coenzyme Q10 market is expected to grow by USD 242.36 million from 2021 to 2025, progressing at a CAGR of 6.13%, according to Technavio. The report offers an up-to-date analysis of the market.

To know the exact growth variance and the Y-O-Y growth rate, Request a Free Sample Report.

The coenzyme Q10 market is fragmented, and the degree of fragmentation will accelerate during the forecast period. The growing disposable income, increase in older adult population, and rising focus on healthy dietary habits will offer immense growth opportunities. However, adverse effects of coenzyme Q10, low adoption in developing countries, and the threat from counterfeit products will challenge the growth of market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.

Coenzyme Q10 Market 2021-2025 : Segmentation

  • Application
    • Dietary Supplements
    • Pharmaceuticals
    • Cosmetics
  • Geography
    • North America
    • Europe
    • Asia
    • ROW

To learn more about the additional trends impacting the growth of individual segments, Download a Free Sample

Coenzyme Q10 Market 2021-2025: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our coenzyme q10 market report covers the following areas:

Coenzyme Q10 Market 2021-2025: Vendor Analysis

Technavio provides a detailed analysis of around 25 vendors operating in the coenzyme Q10 market. Kaneka Corp., Kikkoman Corp., Kirin Holdings Co. Ltd., Koninklijke DSM NV, Lesaffre and Cie, Nisshin Seifun Group Inc., Otsuka Holdings Co. Ltd., Pharma Nord Inc., PharmaEssentia Corp., and Zhejiang Medicine Co. Ltd. are some of the major market participants. Backed with competitive intelligence and benchmarking, our research report on the coenzyme Q10 market is designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.

Subscribe to our «Lite Plan» billed annually at USD 3000 that enables to download 3 reports/year and view 3 reports/month.

Coenzyme Q10 Market 2021-2025: Key Highlights

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will assist coenzyme Q10 market growth during the next five years
  • Estimation of the coenzyme Q10 market size and its contribution to the parent market
  • Predictions on upcoming trends and changes in consumer behavior
  • The growth of the coenzyme Q10 market
  • Analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of coenzyme Q10 market vendors

Related Reports:

  • Enzyme-linked Immunosorbent Assay (Elisa) Market by End-user and Geography – Forecast and Analysis 2021-2025: The enzyme-linked immunosorbent assay (Elisa) testing market has the potential to grow by USD 265.55 mn from 2021 to 2025. Download Free Sample Report
  • Self-Monitoring Blood Glucose Strips Market by End-user and Geography – Forecast and Analysis 2020-2024: The self-monitoring blood glucose strips market size has the potential to grow by USD 10.96 billion from 2020 to 2024. View Exclusive Free Sample

Coenzyme Q10 Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 6.13%

Market growth 2021-2025

USD 242.36 million

Market structure

Fragmented

YoY growth (%)

5.59

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 34%

Key consumer countries

US, UK, Germany, Japan, and China

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Kaneka Corp., Kikkoman Corp., Kirin Holdings Co. Ltd., Koninklijke DSM NV, Lesaffre and Cie, Nisshin Seifun Group Inc., Otsuka Holdings Co. Ltd., Pharma Nord Inc., PharmaEssentia Corp., and Zhejiang Medicine Co. Ltd.

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: media@technavio.com

Website: www.technavio.com/

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/coenzyme-q10-market-size-to-grow-by-usd-242-36-mn-from-2021-2025growing-disposable-income-to-boost-growthtechnavio-301397258.html

SOURCE Technavio